Refine by
Cancer Tissue Suppliers & Manufacturers
57 companies found
based inWarren, NEW JERSEY (USA)
Auspex Diagnostics focuses on developing and providing advanced cancer diagnostics services to medical professionals and patients to help them personalize cancer treatment plans and improve patients’ quality of living. We started developing the ...
Until now, cancer patients and caretakers in various stages often face the dilemma when deciding whether or not to receive chemotherapy as part of the treatment for two primary reasons – uncertainty of future cancer relapse and efficacy of ...
based inFranklin, TENNESSEE (USA)
Created by urologists for urologists, UroTech is the best way to use advanced medical technology: Avoid significant capital expenditures: Purchasing just one of the advanced technologies now available - much less the five offered by UroTech - would ...
Cryoablation is emerging as an effective, minimally invasive treatment for localized prostate cancer. Cryoablation is revolutionizing localized prostate cancer treatment by abolishing the "one shot" treatment method of having only one chance at ...
based inPeachtree Corners, GEORGIA (US) (USA)
Guided Therapeutics, Inc. (OTC: QB GTHP) is committed to developing groundbreaking medical devices using our patented biophotonic technology to detect diseases earlier, more accurately, and more efficiently than other tests. Since Guided ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
based inChuo-ku, JAPAN
Sysmex has a global network of operations throughout the world. This section introduces our company profile and provides the locations of our offices and subsidiaries. Sysmex supports human health. We are an integrated company, developing and ...
In general, gene amplification (such as the RT-PCR method) reaction requires a process to prevent impurities in the sample from affecting the gene amplification reaction. Also, it takes more than one hour for the gene amplification reaction. Sysmex ...
based inMontréal, QUEBEC (CANADA)
Reveal Surgical Develops AI-Enabled Optical Detection Systems for Tumor Margin Assessment and Tissue Characterization. We help surgeons see the unseen, giving them deeper, data-driven insights into the tissues they encounter – increasing confidence ...
Sentry is able to identify within seconds whether the tissue being investigated is cancerous or not. Our technology allows surgeons to safely and precisely remove more cancer than current imaging ...
based inBoston, MASSACHUSETTS (USA)
CervoMed is a clinical stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as ...
based inBrunnthal/Hofolding, GERMANY
WISAP employs specialized staff and manufactures all products exclusively in Germany using the highest quality materials. We as WISAP have established ourselves for more than 60 years as a medium-sized niche supplier of medical instruments and ...
The angular gear MACRO allows the use of reusable cutting tubes with a size of 15mm or 20 mm. The gear head and the instrument cable are autoclavable. The cutting tubes are made of medical grade stainless steel for high performance and ...
based inChicago, ILLINOIS (USA)
GE HealthCare operates as a leader in precision care, integrating advanced technologies with patient-focused solutions to enhance healthcare delivery. The company invests approximately $1 billion annually in research and development, focusing on ...
The Invenia ABUS 2.0 is designed as an FDA-approved ultrasound supplemental screening technology, aiming to improve cancer detection in women with dense breast tissue. It offers a 35.7% increase in detection over ...
based inSunnyvale, CALIFORNIA (USA)
IntraOp is the leading innovator of electron therapy devices for treating cancer. IntraOp’s compact and mobile linear accelerators enable oncologists to deliver effective, precise, and affordable radiation therapy at the point of care. The Mobetron ...
Our flagship product—the Intraop® Mobetron®—is used by the leading cancer physicians in the best hospitals, clinics and academic centers in the world. The Mobetron is the first mobile, self-shielded electron-beam linear ...
based inGuildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
based inCleveland, OHIO (USA)
Advances in cancer diagnostics have enabled the detection of cancer at its earliest stages when the chances for successful intervention are highest. For many tumors, surgery offers the best option for a cure, with the potential to remove all cancer ...
Akrotome Molecular Probes Offer a Precisely-Targeted Intervention for Cancer Surgery. Achieving a surgical cure for cancer depends on “getting it all” – removing all diseased ...
based inKøbenhavn N, DENMARK
Curasight is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor ...
based inGuro-gu, SOUTH KOREA
We provide diagnostic solutions throughout the cancer treatment cycle from early cancer diagnosis to prognostic and companion diagnostics as well as postoperative monitoring. Diagnose cancer as early as possible, when the disease is easiest to ...
Chemotherapy drugs have many side effects such as reduction in white blood cells, hair loss, vomiting because they attack rapidly growing cells without separating cancer cells from normal cells. However targeted therapy drugs have less side effects ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a ...
based inEden Prairie, MINNESOTA (USA)
ProUroCare is engaged in the business of developing innovative products for the detection and characterization of prostate disease. Our initial product is a “prostate mechanical imaging” device called the ProUroScan System. The ProUroScan is an ...
ProUroScan is an advanced medical imaging system that uses an array of sensors mounted on a rectal probe, a central processing unit and software and image construction algorithms to provide a real time color image of abnormalities in the ...
based inIrvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
based inOxford, UNITED KINGDOM
Founded in 2012, we are the leading pharmatech company and the first to automate drug discovery. As a full stack AI drug discovery company, we generate our own data before combining the analytical power of AI with the creativity and expertise of our ...
Only with continual feedback between experiment and prediction can machine learning models be refined and deliver against complex therapeutic ...
based inNewark, CALIFORNIA (USA)
ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and ...
ACD has curated a collection of dozens of pre-sourced validated and un-validated tissue blocks, available to our PAS customers, to support the development of ISH probes and assays. ...
based inDurham, NORTH CAROLINA (USA)
GeneCentric Therapeutics is applying our proprietary rT(I)ME Explorer Platform to identify high resolution molecular subtypes and drug responder populations that enable the development of precision cancer drugs while improving patient outcomes. Our ...
Pancreatic Cancer is the 11th most common cancer type with an estimated 55,000 new cases in the US in 2018, according to the United States National Cancer Institute. While it represents three percent of all cancers, pancreatic cancer is one of the ...